Swiss Pharma Company to Bring $20 Million in Investment to Pakistan

Novartis, a Switzerland based Multinational has acquired a manufacturing facility in Pakistan to produce medicines locally.

Advisor to Prime Minister on Trade and Investment Abdul Razak Dawood announced that the Swiss company has an expansion plan that will bring an investment of about $20 million to Pakistan.

He wrote, “This investment signifies that the regulatory reforms and competitive local landscape is being recognized as an opportunity by investors.” He said that this acquisition also shows the confidence of international companies to invest in the future of the Pakistani pharmaceutical industry and highlights the realization of increased ease in doing business in Pakistan.

As per the financial statements of Novartis, the company maintained strong operational performance in the first quarter of the fiscal year 2020 (Q1 FY 2020) that is July to September. The company’s net sales from continuing operations grew 13 percent with double digits growth in Innovative Medicines and Sandoz.

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Toyota IMC Extends the Warranty Offer for the New Corolla and Yaris

Fauji Foods Reports a Reduction in Losses for Q3 2020